Evidence map›Paper›PMID 26752327›Full record

Trial reportBehaviour research and therapy2016

Anxiety sensitivity risk reduction in smokers: A randomized control trial examining effects on panic.

Norman B Schmidt, Amanda M Raines, Nicholas P Allan, Michael J Zvolensky

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Behaviour research and therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05426837 (Combating Social Isolation in Older Adults), which is not on this map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05426837 nacompletednot on this mapstarted 2022, after this paper: background citation

Combating Social Isolation in Older Adults: Randomized Clinical Trial Evaluating the Acceptability and Efficacy of a Brief, Technology Delivered Intervention

TypeinterventionalSponsorFlorida State UniversityRan2022 to 2024Enrolled70ConditionsLoneliness, Social IsolationArmsCombatting Social Isolation, Health Education Training
3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 83 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Distress intolerance during smoking cessation treatment.Behaviour research and therapy · 2016
    Trial
  12. Trial
  13. Trial
  14. Trial
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Norman B SchmidtFlorida State University, Tallahassee, FL, USA. Electronic address: schmidt@psy.fsu.edu.
Amanda M RainesFlorida State University, Tallahassee, FL, USA.
Nicholas P AllanFlorida State University, Tallahassee, FL, USA.
Michael J ZvolenskyUniversity of Houston, Houston, TX, USA; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Florida State University · USThe University of Texas MD Anderson Cancer Center · US

Funding

Smoking-Based Prevention Program for Panic DisorderR01MH076629 · NIMH · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI FOREHAND, REX · 2007 to 2011
$3.0M
NIMH NIH HHS R01 MH076629NIMH NIH HHS R01 MH076629-0
6 · The paper itself

Abstract

Empirical evidence has identified several risk factors for panic psychopathology, including smoking and anxiety sensitivity (AS; the fear of anxiety-related sensations). Smokers with elevated AS are therefore a particularly vulnerable population for panic. Yet, there is little knowledge about how to reduce risk of panic among high AS smokers. The present study prospectively evaluated panic outcomes within the context of a controlled randomized risk reduction program for smokers. Participants (N = 526) included current smokers who all received a state-of-the-art smoking cessation intervention with approximately half randomized to the AS reduction intervention termed Panic-smoking Program (PSP). The primary hypotheses focus on examining the effects of a PSP on panic symptoms in the context of this vulnerable population. Consistent with prediction, there was a significant effect of treatment condition on AS, such that individuals in the PSP condition, compared to those in the control condition, demonstrated greater decreases in AS throughout treatment and the follow-up period. In addition, PSP treatment resulted in lower rates of panic-related symptomatology. Moreover, mediation analyses indicated that reductions in AS resulted in lower panic symptoms. The present study provides the first empirical evidence that brief, targeted psychoeducational interventions can mitigate panic risk among smokers.

Indexed as

Risk Reduction BehaviorAdolescentAdultAgedAnxietyAnxiety DisordersFearFemaleHumansMaleMiddle AgedPanicPanic DisorderRisk FactorsSmokingSmoking CessationAnxiety sensitivityInterventionPanicPreventionSmokers

Identifiers

PMID26752327
PMCPMC4752863
OpenAlexW2215121710

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.